If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.
We set cookies so you can manage your account and navigate the site, and to remember your cookie preferences so that you don't keep getting this message. To accept cookies, just keep browsing, otherwise use the links on the right to adjust your cookie settings or find out more.
Compounds found in parsley and dill can fight cancer and could be a natural, and safer, alternative to chemotherapy, say Russian scientists. The compounds are the building blocks of an isoflavone that naturally blocks the rapid division of cancer cells.
One week we’re told that coffee is good for us, the next it’s bad. Tired of this flip-flopping health advice, researchers have reviewed 1,277 studies published from the mid-1970s—and discovered that drinking three to four cups a day has a neutral effect on our health, but may be mildly beneficial.
Artificial light in our homes and offices could be an unsuspected cause of diseases ‘of ageing’—such as osteoporosis and muscle loss—that affect our ability to stand and walk. The good news is that the symptoms can be reversed if we spend more time with the lights off when it gets dark.
Researchers who say pregnant women won’t get any benefit from taking mineral and vitamin supplements don’t understand nutrition or diet, a leading dietitian says.
A group of 64 Japanese women are suing their government and two drug companies for suffering serious and long-term adverse reactions to the HPV vaccine. The women, who have an average age of 18, were vaccinated with the Gardasil or Cervarix vaccines, which are designed to protect against cervical cancer, when they were 11 years or older.
All disease begins in the gut, said Hippocrates—and scientists have this week confirmed that rheumatoid arthritis is on the list. Bacteria in the gut are a predictor of the disease, they determine the severity and frequency of symptoms, and they could even help treat or prevent it.
It was the great new wonder drug for advanced prostate cancer. It was approved by America’s drug regulator, the Food and Drug Administration (FDA), in April—and just two months later an independent research group has discovered that cabozantinib, marketed as Cabometyx, is no better than existing products on the market.